Ellen Capon (Drug Target Review)2023-10-12T16:00:09
Researchers pinpoint connections of risk variants with microglia functions that are important for Alzheimer’s disease (AD).
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-08-06T06:08:00Z
Author Dr Jonathan Cohen-Gold
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2026-08-06T06:08:00
Author Dr Jonathan Cohen-Gold
2023-07-04T10:05:58
Sponsored by Revvity
2024-03-08T10:00:25
Sponsored by Molecular Devices
2024-01-26T13:22:42
Sponsored by bit.bio
2023-03-03T14:06:14
Sponsored by Bio-Techne
Site powered by Webvision Cloud